ERBB2 and breast cancer: This is especially the case for miRNA-21, the miRNA-125 family, miR-155, and miR-205, which seem to play a relevant role in BC development, diagnosis, prognosis, and prediction [5,41], although other miRNAs were also reported to have a considerable influence on the progression of HER2+ BC [42,43,44,45].